Market Place
Sourcing Support
Zent2U announces completion of Bisoprolol oral solution development
16 Apr 2024 //
PRESS RELEASE
World Health Day 2024: "My health, my right“
07 Apr 2024 //
PRESS RELEASE
Elevating our Customer Experience with a New Supply Chain Member!
28 Mar 2024 //
PRESS RELEASE
Zent2U and Gedeon Richter Expand Access to Amlodipine + Indapamide + Perindopril
19 Mar 2024 //
PRESS RELEASE
Zentiva registered Omeprazole Value Added Medicine
14 Mar 2024 //
PRESS RELEASE
Zent2U adding innovative formulation in the pain relief portfolio
21 Feb 2024 //
PRESS RELEASE
Go west! See you soon at euroPLX 84 in Lisbon
14 Feb 2024 //
PRESS RELEASE
Welcoming Our New Portfolio Manager!
07 Feb 2024 //
PRESS RELEASE
Towards the excellence: new collaboration with Prague Scientific
30 Jan 2024 //
PRESS RELEASE
Successful Completion of Bioequivalence Study on Vortioxetine
10 Jan 2024 //
PRESS RELEASE
The dossier of Edoxaban is available for B2B partners!
13 Sep 2023 //
PRESS RELEASE
Partnership in the treatment of thromboembolic disease
02 Aug 2023 //
PRESS RELEASE
The dossier of Apremilast is available for B2B partners!
17 May 2023 //
PRESS RELEASE
A convenient treatment option for Thromboembolic Events
10 Apr 2023 //
PRESS RELEASE
New Product Available for out-licensing!
31 Mar 2023 //
PRESS RELEASE
Joint investment in the new aseptic line
14 Mar 2023 //
PRESS RELEASE
All the meetings at once - euroPLX 81 Lisbon already this March!
28 Dec 2022 //
PRESS RELEASE
Successful pivotal bioequivalence study results on Omeprazole Immediate Release Capsules
27 Dec 2022 //
PRESS RELEASE
Business development & licensing pharma community all together again this week!
22 Dec 2022 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.